
Ekazone S 1000mg/500mg Injection
Marketer
Ekasar Lifescience
Salt Composition
Cefoperazone (1000mg) + Sulbactam (500mg)
Overview Ekazone S 1000mg/500mg Injection
Combiflox, a 1000mg/500mg injectable dual-action antibiotic, combats diverse bacterial infections by hindering microbial proliferation. Administration must be strictly under medical guidance; complete the prescribed regimen, even with symptom improvement, to maximize efficacy. Premature cessation may compromise treatment. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent reactions necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) require emergency care. Inform your physician of all current medications, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if somnolence or dizziness occurs. Adequate rest, balanced nutrition, and ample hydration promote recovery. Your doctor may order tests to monitor the medication's impact.
Uses of Ekazone S 1000mg/500mg Injection
Combating Bacterial Infections
Major Benefits of Ekazone S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ekazone S 1000mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Ekazone S 1000mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Ekazone S 1000mg/500mg Injection works:
Ekazone S Injection (1000mg/500mg) combines cefoperazone, a bacterial cell wall synthesis inhibitor, with sulbactam, a beta-lactamase inhibitor. This dual action combats bacterial infections by disrupting bacterial cell wall formation (via cefoperazone) and preventing bacterial enzyme degradation of cefoperazone (via sulbactam), thus maximizing its antibiotic effect.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Ekazone S 1000mg/500mg Injection and alcohol can trigger adverse reactions, including facial flushing, tachycardia, nausea, polydipsia, chest discomfort, and hypotension (a disulfiram-like effect).
PregnancySAFE IF PRESCRIBED
The injectable medication Ekazone S (1000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Ekazone S 1000mg/500mg Injection poses minimal risk during lactation. Research in humans indicates negligible transfer of the medication into breast milk, presenting no discernible harm to the infant.
DrivingCONSULT YOUR DOCTOR
Ekazone S 1000mg/500mg Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Ekazone S 1000mg/500mg Injection to individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ekazone S 1000mg/500mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Ekazone S 1000mg/500mg Injection :
Omit a scheduled Ekazone S 1000mg/500mg Injection? Seek medical advice.
Facts to Know About Ekazone S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
